A top Research Triangle based venture capital investor shares an overview of the life sciences ecosystem in North Carolina
Gauging biotech investor sentiment with RBC's Healthcare Desk Sector Strategist
Catching up with Roberto Bellini one year after he sold BELLUS Health to GSK for $2 billion
A banker's perspective on the current state of biotech with RBC's Noël Brown
RBC's Brian Abrahams kicks off the 2024 RBC Capital Markets Global Healthcare Conference
Genetic medicines expert Emily Walsh Martin shares learnings from Day 2 of #ASGCT2024
Previewing the 2024 ASGCT Annual Meeting in Baltimore with gene editing expert TJ Cradick
A computational biologist and assistant professor at Philadelphia’s Wistar Institute on positives and potential negatives of AI’s emergence to the forefront of life sciences
Founder Mark Kotter describes the science that has enabled bit.bio to design and manufacture virtually any cell type and characteristic from iPSCs
How Cambridge Innovation Capital has become a preeminent investment firm in Cambridge life sciences, and also a significant attractor of outside capital to Cambridge
Innovate Cambridge's new executive director shares an overview of the key points and institutions to know within Cambridge life sciences
How The Milner Therapeutics Institute at University of Cambridge plays key roles in the life sciences ecosystem
Penn Medicine's Jakub Svoboda describes a CD19 CAR-T that has been armored with IL18 and is being studied for CAR-T relapse patients
How Oxford Science Enterprises shapes biotech companies from University of Oxford science
A venture capital investor's take on the UK life sciences funding environment - with Alek Safarian of ALSA Ventures
Penn Medicine's Dr. Donald O'Rourke describes advances being seen today in using CAR-T against glioblastoma
Talking transfer RNA for cancer and the biotech ecosystem for startups with Cloverleaf Bio's Austin Draycott
Lucy Perez and Vivek Arora from McKinsey talk women's health, ESG, and helping with the Align Summit
Issi Rozen describes GV's (Google Ventures) investments in healthcare and life sciences
MassBio's CEO on the Align Summit and supporting the innovation ecosystem in Massachusetts
.png){kind=logo}
